ResearcherUniversity of FreiburgNo recent work listed

Costantinos Zamboglou

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-7849-7550; OpenAlex author ID A5085968028, A5110700806. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 2

Papers, trials and grants by year

2015: 1 paper · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: 1 paper

Papers 2

FAK inhibition radiosensitizes pancreatic ductal adenocarcinoma cells in vitro. Co-author DOI 10.1007/s00066-020-01666-0 ↗
Radiotherapy for SMAD4-negative musculoskeletal lesions from pancreatic cancer: case report and review. Co-author DOI 10.1007/s00066-014-0764-4 ↗

Closest collaborators

The 2 strongest of 2 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Thomas Baptist Brunner · 2 shared papers, 2015–2021 · strength 0.19
- Paper FAK inhibition radiosensitizes pancreatic ductal adenocarcinoma cells in vitro. DOI 10.1007/s00066-020-01666-0 ↗
- Paper Radiotherapy for SMAD4-negative musculoskeletal lesions from pancreatic cancer: case report and review. DOI 10.1007/s00066-014-0764-4 ↗
Ahmed Allam Mohamed · 1 shared paper, 2021 · strength 0.13
- Paper FAK inhibition radiosensitizes pancreatic ductal adenocarcinoma cells in vitro. DOI 10.1007/s00066-020-01666-0 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.